Effects of Carbohydrate in Diet and Supplements on the Gastrointestinal Tolerability of LIK066
Completed · Phase 2
Conditions studied: Obesity
In brief
The purpose of this study was to determine if LIK066 taken with a meal containing low carbohydrate is associated with less diarrhea compared to a high carbohydrate meal and to assess the potential effects of supplements such as psyllium or calcium carbonate on alleviating diarrhea associated with LIK066.
Key facts
- Study ID
- NCT03198767
- Run by
- Novartis Pharmaceuticals
- People needed
- 54
- Starts
- 2017-06-21
- Expected to finish
- 2017-09-04
- Last updated by the study team
- 2021-01-05
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- obese and overweight, BMI 25-50, HbA1C <10%
You may not qualify if…
- Preexisting, clinically significant cardiovascular, liver, renal, or GI disease that is considered unstable; pregnancy, Type 1 diabetes; Other protocol-defined inclusion/exclusion criteria may apply
Where it is running
- Novartis Investigative Site — Lincoln, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.